Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Toronto

$25,000.00

Relationship of hydrophobicity and membrane permeability in macrocycles

EF 2014-15

Résumé
Encycle Therapeutics is a Canadian start-up company that uses a unique chemistry platform, developed by the laboratory of Dr. Andrei Yudin at the University of Toronto, to make novel, drug-like molecules called macrocycles. For these molecules to become effective drugs, Encycle needs to be able to predict whether or not a macrocycle can be absorbed by the body when taken by mouth as a pill. This is critical because absorption of a drug taken in pill form depends on the ability of the drug molecule to cross the membranes of the small intestine. While companies usually estimate if a drug will cross membranes with a set of parameters called Lipinski's Rule of Five before trying out drug absorption measurements, the unique chemistry that makes macrocycles such exciting potential drugs also makes it challenging to use Lipinski's rules to decide if they willcross membranes. Therefore, the project described in this proposal will determine a method to predict the ability of macrocycles to cross membranes. We will measure factors that are important for crossing membranes, such as sequence of the amino acids in the macrocycle, structure, and ability to dissolve in oil or in water (called 'hydrophobicity') among a set of macrocycles. The ability of the same set of macrocycles to cross membranes will also be measured. We will then combine the results of the experiments to produce a new set of rules by which the membrane-crossing ability - and thereby drug potential - of a macrocycle molecule can be confidently predicted.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
462841-2014
Name nom
Deber, Charles
Department département
Biochemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Relationship of hydrophobicity and membrane permeability in macrocycles
Keyword
NSERC
Application summary
Encycle Therapeutics is a Canadian start-up company that uses a unique chemistry platform, developed by the laboratory of Dr. Andrei Yudin at the University of Toronto, to make novel, drug-like molecules called macrocycles. For these molecules to become effective drugs, Encycle needs to be able to predict whether or not a macrocycle can be absorbed by the body when taken by mouth as a pill. This is critical because absorption of a drug taken in pill form depends on the ability of the drug molecule to cross the membranes of the small intestine. While companies usually estimate if a drug will cross membranes with a set of parameters called Lipinski's Rule of Five before trying out drug absorption measurements, the unique chemistry that makes macrocycles such exciting potential drugs also makes it challenging to use Lipinski's rules to decide if they willcross membranes. Therefore, the project described in this proposal will determine a method to predict the ability of macrocycles to cross membranes. We will measure factors that are important for crossing membranes, such as sequence of the amino acids in the macrocycle, structure, and ability to dissolve in oil or in water (called 'hydrophobicity') among a set of macrocycles. The ability of the same set of macrocycles to cross membranes will also be measured. We will then combine the results of the experiments to produce a new set of rules by which the membrane-crossing ability - and thereby drug potential - of a macrocycle molecule can be confidently predicted.